+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Age Related Macular Degeneration"

Age-Related Macular Degeneration Global Market Report 2024 - Product Thumbnail Image

Age-Related Macular Degeneration Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Global Age-related Macular Degeneration Market 2024-2028 - Product Thumbnail Image

Global Age-related Macular Degeneration Market 2024-2028

  • Report
  • December 2023
  • 158 Pages
  • Global
From
From
From
From
Eyewear Global Market Report 2024 - Product Thumbnail Image

Eyewear Global Market Report 2024

  • Report
  • February 2024
  • 200 Pages
  • Global
From
Macular Degeneration Treatment Global Market Report 2024 - Product Thumbnail Image

Macular Degeneration Treatment Global Market Report 2024

  • Report
  • February 2024
  • 200 Pages
  • Global
From
Retinal Biologics Global Market Report 2024 - Product Thumbnail Image

Retinal Biologics Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Loading Indicator

Age-related Macular Degeneration (AMD) is a degenerative eye condition that affects the macula, the part of the eye responsible for central vision. It is the leading cause of vision loss in people over the age of 50. AMD is a major concern for the optical industry, as it can lead to severe vision impairment and blindness. Optical companies are developing treatments and technologies to help diagnose and manage AMD. These include optical coherence tomography (OCT) imaging, which can detect early signs of AMD, and anti-VEGF drugs, which can slow the progression of the disease. Additionally, companies are developing new lenses and other optical devices to help improve vision in those with AMD. Companies in the AMD market include Novartis, Regeneron, Allergan, Genentech, and Roche. Show Less Read more